[go: up one dir, main page]

CY1118148T1 - Συνθεση που περιεχει ενωσεις τεταρτοταγους αμμωνιου - Google Patents

Συνθεση που περιεχει ενωσεις τεταρτοταγους αμμωνιου

Info

Publication number
CY1118148T1
CY1118148T1 CY20161100773T CY161100773T CY1118148T1 CY 1118148 T1 CY1118148 T1 CY 1118148T1 CY 20161100773 T CY20161100773 T CY 20161100773T CY 161100773 T CY161100773 T CY 161100773T CY 1118148 T1 CY1118148 T1 CY 1118148T1
Authority
CY
Cyprus
Prior art keywords
weight
replaced
carbon atoms
alkyl group
composition containing
Prior art date
Application number
CY20161100773T
Other languages
English (en)
Inventor
Laura Rabinovich-Guilatt
Grégory Lambert
Frédéric Lallemand
Betty Philips
Original Assignee
Santen Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65014357&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1118148(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP06291236.5A external-priority patent/EP1891939B1/en
Priority claimed from US11/494,493 external-priority patent/US20080026013A1/en
Application filed by Santen Sas filed Critical Santen Sas
Publication of CY1118148T1 publication Critical patent/CY1118148T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/143—Quaternary ammonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/62—Quaternary ammonium compounds
    • C07C211/63—Quaternary ammonium compounds having quaternised nitrogen atoms bound to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Αυτή η εφεύρεση σχετίζεται με συνθέσεις που περιέχουν ενώσεις του τεταρτοταγούς αμμωνίου στις οποίες το άτομο αζώτου είναι αντικατεστημένο με τουλάχιστον μία ομάδα αλκυλίου (alkyl) που έχει τουλάχιστον 12 άτομα άνθρακα, που χαρακτηρίζεται από το ότι η εν λόγω σύνθεση περιλαμβάνει τουλάχιστον 20% σε βάρος ανά βάρος της ολικής σύνθεσης, αλογονίδια αμμωνίου στα οποία το άτομο αζώτου είναι αντικατεστημένο με τουλάχιστον μία ομάδα αλκυλίου (alkyl) που έχει τουλάχιστον 14 άτομα άνθρακα και περισσότερα από 5 %, κατά προτίμηση περισσότερο από 7 % σε βάρος ανά βάρος της ολικής σύνθεσης, αλογονίδια αμμωνίου στα οποία το άτομο αζώτου είναι αντικατεστημένο με τουλάχιστον μία ομάδα αλκυλίου (alkyl) που έχει τουλάχιστον 16 άτομα άνθρακα. Αυτή η εφεύρεση σχετίζεται επίσης με οφθαλμικά γαλακτώματα λαδιού μέσα σε νερό που περιέχουν τέτοιες συνθέσεις που είναι χρήσιμες για την φροντίδα των ματιών ή για την θεραπεία παθήσεων των ματιών.
CY20161100773T 2006-07-28 2016-08-05 Συνθεση που περιεχει ενωσεις τεταρτοταγους αμμωνιου CY1118148T1 (el)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP06291236.5A EP1891939B1 (en) 2006-07-28 2006-07-28 Compositions containing quaternary ammonium compounds
US11/494,493 US20080026013A1 (en) 2006-07-28 2006-07-28 Compositions containing quaternary ammonium compounds
EP07112097 2007-07-09
PCT/IB2007/053441 WO2008035246A2 (en) 2006-07-28 2007-07-10 Compositions containing quaternary ammonium compounds
EP07787998.9A EP2049079B1 (en) 2006-07-28 2007-07-27 Compositions containing quaternary ammonium compounds
EP11165011.5A EP2404593B1 (en) 2006-07-28 2007-07-27 Composition containing quaternary ammonium compounds

Publications (1)

Publication Number Publication Date
CY1118148T1 true CY1118148T1 (el) 2017-06-28

Family

ID=65014357

Family Applications (3)

Application Number Title Priority Date Filing Date
CY20161100773T CY1118148T1 (el) 2006-07-28 2016-08-05 Συνθεση που περιεχει ενωσεις τεταρτοταγους αμμωνιου
CY20161101244T CY1118436T1 (el) 2006-07-28 2016-12-02 Συνθεσεις που περιεχουν ενωσεις τεταρτοταγους αμμωνιου
CY2017007C CY2017007I1 (el) 2006-07-28 2017-02-22 Συνθεσεις που περιεχουν ενωσεις τεταρτοταγους αμμωνιου

Family Applications After (2)

Application Number Title Priority Date Filing Date
CY20161101244T CY1118436T1 (el) 2006-07-28 2016-12-02 Συνθεσεις που περιεχουν ενωσεις τεταρτοταγους αμμωνιου
CY2017007C CY2017007I1 (el) 2006-07-28 2017-02-22 Συνθεσεις που περιεχουν ενωσεις τεταρτοταγους αμμωνιου

Country Status (17)

Country Link
US (7) US7973081B2 (el)
EP (2) EP2404593B1 (el)
JP (1) JP5441058B2 (el)
KR (2) KR101507097B1 (el)
AU (1) AU2007278141B2 (el)
CA (1) CA2659322C (el)
CY (3) CY1118148T1 (el)
DK (2) DK2404593T3 (el)
ES (2) ES2606467T3 (el)
HU (2) HUE030841T2 (el)
IL (2) IL196740A (el)
LT (2) LT2049079T (el)
LU (1) LUC00006I2 (el)
PL (2) PL2404593T3 (el)
PT (2) PT2049079T (el)
SI (2) SI2404593T1 (el)
WO (2) WO2008035246A2 (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2916636B1 (fr) * 2007-05-29 2009-09-04 Octalia Technologies Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation ophtalmique ou dermocosmetique
CA2725523C (en) * 2008-05-28 2017-01-10 Alcon Research, Ltd. Self-preserved emulsions
EP2228058A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
EP2228057A1 (en) * 2009-03-04 2010-09-15 Novagali Pharma S.A. Cationic oil-in-water emulsions containing prostaglandins and uses thereof
BRPI1009982A2 (pt) 2009-05-01 2017-06-27 Signal Investment & Man Co composição antimicrobiana hidratante
CA2764802A1 (en) 2009-06-05 2010-12-09 Allergan, Inc. Artificial tears and therapeutic uses
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
WO2013098841A1 (en) * 2011-10-31 2013-07-04 Fdc Limited Nanodispersion of poorly water soluble drug(s)
PL2787969T3 (pl) * 2011-12-07 2021-12-20 Allergan, Inc. Skuteczne dostarczanie lipidów do ludzkiego filmu łzowego z zastosowaniem układu emulsji wrażliwej na sól
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
CA2947274C (en) * 2014-04-28 2019-03-19 Hampton Technologies Ophthalmic compositions and methods for treating eyes
US20160074178A1 (en) * 2014-09-17 2016-03-17 Van Phillips METHODS FOR PREPARING PRECISELY FITTED CASTS for PROSTHETICS
EP3011959A1 (en) * 2014-10-23 2016-04-27 Santen SAS Quaternary ammonium compound for use as an inhibitor of protein kinase C alpha
US10279005B2 (en) 2014-11-25 2019-05-07 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
US11324800B2 (en) 2015-01-15 2022-05-10 Wellspring Ophthalmics, Inc. Aqueous suspensions of cyclosporin
US20200237859A1 (en) 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
PL3266446T3 (pl) * 2016-07-07 2019-05-31 Salvat Lab Sa Kompozycja oftalmiczna zawierająca olej rycynowy i trójgliceryd o średniej długości łańcucha
HRP20250306T1 (hr) * 2020-09-18 2025-04-25 Omnivision Gmbh Oftalmološki pripravak na bazi lipida za liječenje suhog oka
US20230398175A1 (en) 2020-11-09 2023-12-14 Scai Therapeutics Solid cyclosporin a and dispersion composition comprising same
US11471475B1 (en) 2022-03-08 2022-10-18 Ralph P. Stone Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
US20240009124A1 (en) * 2022-07-05 2024-01-11 Primera Compounding, LLC Ophthalmic Suspension Base having a Micro-fluidized Positively Charged Nanoparticle
WO2024069490A1 (en) * 2022-09-28 2024-04-04 Polaroid Ip B.V. Antimicrobial coating compositions
WO2024226686A2 (en) * 2023-04-24 2024-10-31 Emory University Aminoadipate-semialdehyde synthase inhibitors and methods of treating cancer
TR2023007877A2 (tr) * 2023-07-06 2023-10-23 Ardi̇ Farma İlaç Pazarlama Ti̇caret Li̇mi̇ted Şi̇rketi̇ Stabi̇l çoklu doz si̇klospori̇n yağ i̇çi̇nde su emülsi̇yon kompozi̇syonlari

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB633175A (en) * 1946-09-03 1949-12-12 Parke Davis & Co Antibiotic preparations and process for obtaining the same
USB724600I5 (el) * 1968-04-26
AU499860B2 (en) 1975-04-24 1979-05-03 Honda Giken Kogyo Kabushiki Kaisha Deflector plate to equalise fuel distribution in induction gas flow
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
FR2648462B1 (fr) * 1989-06-15 1994-01-28 Oreal Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede
JPH05116286A (ja) 1991-10-25 1993-05-14 Matsushita Electric Ind Co Ltd インク吐出装置
IL101241A (en) 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
IL103907A0 (en) * 1992-11-27 1993-04-04 Pharmos Corp Ophthalmic compositions
CA2142103C (en) 1992-08-28 2003-07-08 Haim Aviv Submicron emulsions as ocular drug delivery vehicles
US5951988A (en) * 1993-03-30 1999-09-14 University Of Saskatchewan Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods
FI108514B (fi) 1993-06-25 2002-02-15 Cusi Lab Polymeerimembraanien käyttö sellaisten farmaseuttisten liuosten jakelussa, jotka sisältävät kvaternäärisiä ammoniumyhdisteitä
ATE227114T1 (de) * 1993-08-30 2002-11-15 Unilever Nv Haarwasch- und konditionierungsmittel
DE69527624T2 (de) 1994-05-20 2003-04-03 Novavax, Inc. Antimikrobielle öl-in-wasser-emulsionen
US5547990A (en) * 1994-05-20 1996-08-20 Lonza, Inc. Disinfectants and sanitizers with reduced eye irritation potential
US5435998A (en) * 1994-08-03 1995-07-25 Abelson; Mark B. Treatment of low-tension glaucoma by topical administration of calcium channel blocking agents
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
US5767153A (en) 1995-06-07 1998-06-16 Insite Vision Incorporated Sustained release emulsions
TW446563B (en) * 1996-01-16 2001-07-21 Colgate Palmolive Co Low static conditioning shampoo
US6071904A (en) 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
DE69807281T2 (de) 1997-05-14 2003-04-17 Mitsubishi Chemical Corp., Tokio/Tokyo Difluprednat enthaltende Zusammensetzungen
US20020169138A1 (en) * 1997-10-24 2002-11-14 Southern Research Institute Delivery vehicles for bioactive agents and uses thereof
AU3548499A (en) 1998-04-02 1999-10-25 Schepens Eye Research Institute, Inc., The Corneal organ culture system for chemical toxicity tests of consumer products
FR2780879B1 (fr) * 1998-07-09 2002-09-20 Oreal Composition cosmetique photoprotectrice contenant un tensio-actif anionique, un compose filtrant le rayonnement ultraviolet et un compose cationique ou zwitterionique amphiphile et son utilisation
EP1115406A4 (en) * 1998-09-25 2003-03-05 Alcon Lab Inc PLEASANT OPHTHALMIC COMPOSITION, DELAYED DELIVERY OF ACTIVE SUBSTANCES AND METHODS FOR EYE TREATMENT
US6030789A (en) 1999-03-10 2000-02-29 The Gillette Company Human conjunctival epithelial cell lines with an extended life span
US6635676B2 (en) 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
DK1214056T3 (da) 1999-09-24 2004-02-09 Alcon Inc Topiske suspensionsformuleringer indeholdende ciprofloxacin og dexamethason
EP1142566B1 (fr) 2000-04-07 2003-10-01 Laboratoire Medidom S.A. Formulations ophtalmiques à base de ciclosporine, d'acide hyaluronique et du polysorbate
US20030017181A1 (en) * 2001-05-31 2003-01-23 Rood Gloria A. Dermatological compositions and methods
US7314624B2 (en) 2001-06-05 2008-01-01 The Regents Of The University Of Michigan Nanoemulsion vaccines
US6872705B2 (en) 2001-07-13 2005-03-29 Allergan, Inc. Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
US6656460B2 (en) * 2001-11-01 2003-12-02 Yissum Research Development Method and composition for dry eye treatment
CN100335036C (zh) 2001-11-01 2007-09-05 耶路撒冷希伯来语大学依苏姆研究开发公司 用于干眼症治疗的方法和组合物
US20030165545A1 (en) * 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
AU2003230691A1 (en) 2002-03-20 2003-10-08 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
JP5382972B2 (ja) 2003-12-26 2014-01-08 ロート製薬株式会社 粘度低下が防止された組成物
US20050175651A1 (en) 2004-01-09 2005-08-11 L'oreal Aqueous dispersion of nanocapsules with an oily core
US20050158349A1 (en) 2004-01-20 2005-07-21 Jampani Hanuman B. Two-phase compositions containing alcohol
EP1611879B1 (en) 2004-07-02 2009-08-12 Novagali Pharma SA Use of emulsions for intra- and periocular injection
EP1655021B1 (en) * 2004-11-09 2008-10-29 Novagali Pharma SA Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential
CA2586074C (en) 2004-11-09 2013-07-23 Novagali Pharma Sa Ophthalmic oil-in-water type emulsion with stable positive zeta potential
AU2007208169A1 (en) 2006-01-30 2007-08-02 Lawrence R. Bernstein Use of gallium to treat biofilm-associated infectons
US20080026013A1 (en) * 2006-07-28 2008-01-31 Laura Rabinovich-Guilatt Compositions containing quaternary ammonium compounds
US20090018057A1 (en) * 2007-07-09 2009-01-15 Gregory Lambert OIL IN WATER EMULSION COMPRISING NSAIDs AND QUATERNARY AMMONIUM HALIDES

Also Published As

Publication number Publication date
PT2404593T (pt) 2016-08-16
SI2404593T1 (sl) 2016-11-30
IL241753B (en) 2018-03-29
AU2007278141A1 (en) 2008-01-31
HUE029987T2 (en) 2017-04-28
JP2009544667A (ja) 2009-12-17
US11612658B2 (en) 2023-03-28
US9956289B2 (en) 2018-05-01
WO2008035246A3 (en) 2008-06-26
PT2049079T (pt) 2016-12-09
DK2404593T3 (en) 2016-08-29
US8524779B2 (en) 2013-09-03
LUC00006I2 (el) 2017-05-02
KR101507465B1 (ko) 2015-03-31
US20110201689A1 (en) 2011-08-18
HK1165993A1 (en) 2012-10-19
US20210038721A1 (en) 2021-02-11
KR101507097B1 (ko) 2015-03-31
WO2008012367A2 (en) 2008-01-31
US10842873B2 (en) 2020-11-24
CY2017007I2 (el) 2017-06-28
JP5441058B2 (ja) 2014-03-12
EP2049079B1 (en) 2016-09-07
US9220694B2 (en) 2015-12-29
ES2606467T3 (es) 2017-03-24
IL196740A (en) 2015-10-29
LT2049079T (lt) 2016-12-12
US20200000924A9 (en) 2020-01-02
EP2049079A2 (en) 2009-04-22
WO2008035246A2 (en) 2008-03-27
LTPA2017003I1 (lt) 2017-03-10
LUC00006I1 (el) 2017-02-28
KR20090047496A (ko) 2009-05-12
US20080026991A1 (en) 2008-01-31
WO2008012367A3 (en) 2008-05-29
DK2049079T3 (da) 2017-01-02
CY2017007I1 (el) 2017-06-28
US20130337019A1 (en) 2013-12-19
IL196740A0 (en) 2009-11-18
IL241753A0 (en) 2015-11-30
EP2404593A1 (en) 2012-01-11
EP2404593B1 (en) 2016-05-11
CY1118436T1 (el) 2017-06-28
CA2659322A1 (en) 2008-01-31
CA2659322C (en) 2014-07-15
KR20140041845A (ko) 2014-04-04
US20160082107A1 (en) 2016-03-24
ES2586381T3 (es) 2016-10-14
US20230181738A1 (en) 2023-06-15
AU2007278141B2 (en) 2014-01-16
HUE030841T2 (en) 2017-06-28
SI2049079T1 (sl) 2017-03-31
US7973081B2 (en) 2011-07-05
PL2049079T3 (pl) 2017-03-31
US20190022231A1 (en) 2019-01-24
PL2404593T3 (pl) 2016-11-30
LTC2049079I2 (lt) 2019-12-27

Similar Documents

Publication Publication Date Title
CY1118148T1 (el) Συνθεση που περιεχει ενωσεις τεταρτοταγους αμμωνιου
CY1118096T1 (el) Ρυθμιστες υποδοχεα οπιοειδους
CY1107871T1 (el) Παραγωγα πυριμιδινης και η χρηση τους ως ρυθμιστων cb2
EA202193338A1 (ru) Терапевтические композиции, включающие дейтерированные или частично дейтерированные соединения n,n-диметилтриптамина
CY1106674T1 (el) Αζαδικυκλικοι ετεροκυκλοι σαν ρυθμιστες υποδοχεα κανναβινοειδους
CY1114457T1 (el) Συνθεσεις που περιεχουν ενωσεις τεταρτοταγους αμμωνιου (quaternary ammonium)
CY1121162T1 (el) M-csf-ειδικο μονοκλωνικο αντισωμα και χρησεις αυτου
CY1121898T1 (el) Ενωσεις αμιδιου ως αγωνιστες tου υποδοχεα 5-ht4
EA200600048A1 (ru) Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором
CY1118846T1 (el) Τριαζολοπυριδαζινες ως ρυθμιστες της κινασης τυροσινης
CY1121865T1 (el) Οφθαλμολογικες συνθεσεις και η χρηση τους
CY1118299T1 (el) Ανοσοκατασταλτικες ενωσεις και συνθεσεις
BRPI0414313A (pt) inibidores de citocinas
CY1109860T1 (el) Παραγοντες υποδοχεα ισταμινης η3, παρασκευη και θεραπευτικες χρησεις
CY1115489T1 (el) ΠΑΡΑΛΛΑΓΜΑΤΑ ΠΡΟΕΡΧΟΜΕΝΑ ΑΠΟ ActRIIB ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
CY1110419T1 (el) Τρικυκλικες ενωσεις με βαση το 1,6-διυδρο-1,3,5,6-tetpaaza-as-ινδακενιο και φαρμακευτικες συνθεσεις που τις περιεχουν ως αναστολεις της ενζυμικης ενεργοτητας της ικκ
PT729468E (pt) Antagonistas nao peptidicos de receptores de taquiquininas
CY1110343T1 (el) 2-(πυριδιν-2-υλο)-πυριμιδινες και η χρησιμοποιηση του για την καταπολεμηση επιζημιων μυκητων
ATE430744T1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
CY1113257T1 (el) Παραγωγα βενζυλοπιπεραζινης τα οποια ειναι χρησιμα στη θεραπεια γαστρεντερικων διαταραχων
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
CY1109214T1 (el) Μειγματα μυκητοκτονου που βασιζονται σε παραγωγα καρβαμικου και εντομοκτονα
AR053196A1 (es) N- (pirimidin -2-il-metil) carboxamidas y su empleo como herbicidas y reguladores del crecimiento de las plantas y un procedimiento para combatir plantas no deseadas que las utiliza.
CY1114735T1 (el) Θεραπευτικες συνθεσεις οι οποιες περιεχουν εναν ειδικο ανταγωνιστη του υποδοχεα της ενδοθηλινης και εναν αναστολεα της pde5
SA522431498B1 (ar) مشتقات 3، 6-داي أمينو-بيريدازين-3-يل، تركيبات صيدلية تحتوي عليها واستخدامها في صورة عوامل مساعدة على تلاشي الخلايا